Literature DB >> 30085019

A Single Nucleoside Viral Polymerase Inhibitor Against Norovirus, Rotavirus, and Sapovirus-Induced Diarrhea.

Jana Van Dycke1, Francesca Arnoldi2,3, Guido Papa2, Justine Vandepoele1, Oscar R Burrone2, Eloise Mastrangelo4, Delia Tarantino4, Elisabeth Heylen1, Johan Neyts1, Joana Rocha-Pereira1.   

Abstract

A safe and highly efficient antiviral is needed for the prophylaxis and/or treatment of viral diarrhea. We here demonstrate the in vitro antiviral activity of four 2'-C-methyl nucleoside analogues against noro-, rota-, and sapoviruses. The most potent nucleoside analogue, 7-deaza-2'-C-methyladenosine, inhibits replication of these viruses with a 50% effective concentration < 5 µM. Mechanistically, we demonstrate that the 2'-C-methyl nucleoside analogues act by inhibiting transcription of the rotavirus genome. This provides the first evidence that a single viral-diarrhea-targeted treatment can be developed through a viral-polymerase-targeting small molecule.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30085019     DOI: 10.1093/infdis/jiy398

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  11 in total

1.  The 13th International Double-Stranded RNA Virus Symposium, Houffalize, Belgium, 24 to 28 September 2018.

Authors:  Ulrich Desselberger
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

2.  2'-C-methylated nucleotides terminate virus RNA synthesis by preventing active site closure of the viral RNA-dependent RNA polymerase.

Authors:  Alyson K Boehr; Jamie J Arnold; Hyung S Oh; Craig E Cameron; David D Boehr
Journal:  J Biol Chem       Date:  2019-10-01       Impact factor: 5.157

Review 3.  Treading a HOSTile path: Mapping the dynamic landscape of host cell-rotavirus interactions to explore novel host-directed curative dimensions.

Authors:  Upayan Patra; Urbi Mukhopadhyay; Arpita Mukherjee; Shanta Dutta; Mamta Chawla-Sarkar
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

Review 4.  Targeting the Viral Polymerase of Diarrhea-Causing Viruses as a Strategy to Develop a Single Broad-Spectrum Antiviral Therapy.

Authors:  Marcella Bassetto; Jana Van Dycke; Johan Neyts; Andrea Brancale; Joana Rocha-Pereira
Journal:  Viruses       Date:  2019-02-20       Impact factor: 5.048

Review 5.  Human Norovirus: Experimental Models of Infection.

Authors:  Kyle V Todd; Ralph A Tripp
Journal:  Viruses       Date:  2019-02-12       Impact factor: 5.048

6.  The Adenosine Analogue NITD008 has Potent Antiviral Activity against Human and Animal Caliciviruses.

Authors:  Daniel Enosi Tuipulotu; Tulio M Fumian; Natalie E Netzler; Jason M Mackenzie; Peter A White
Journal:  Viruses       Date:  2019-05-30       Impact factor: 5.048

Review 7.  Caliciviridae Other Than Noroviruses.

Authors:  Ulrich Desselberger
Journal:  Viruses       Date:  2019-03-21       Impact factor: 5.048

8.  Structural Basis of SARS-CoV-2 Polymerase Inhibition by Favipiravir.

Authors:  Qi Peng; Ruchao Peng; Bin Yuan; Min Wang; Jingru Zhao; Lifeng Fu; Jianxun Qi; Yi Shi
Journal:  Innovation (N Y)       Date:  2021-01-18

Review 9.  Advances in the Development of Antiviral Compounds for Rotavirus Infections.

Authors:  María Julieta Tohmé; Laura Ruth Delgui
Journal:  mBio       Date:  2021-05-11       Impact factor: 7.867

10.  A Novel Class of Norovirus Inhibitors Targeting the Viral Protease with Potent Antiviral Activity In Vitro and In Vivo.

Authors:  Jana Van Dycke; Wenhao Dai; Zoe Stylianidou; Jian Li; Arno Cuvry; Emma Roux; Bingqian Li; Jasper Rymenants; Lindsey Bervoets; Peter de Witte; Hong Liu; Johan Neyts; Joana Rocha-Pereira
Journal:  Viruses       Date:  2021-09-16       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.